Dr Mark Gallardo, MD, will be presenting two-year results for MINIject in our STAR II trial at the 2022 American Glaucoma Society Annual Meeting which starts 3 March, and runs until 6 March at the Grand Hyatt hotel in Nashville, TN.
The American Glaucoma Society (AGS) is comprised of Glaucoma Specialists dedicated to sharing clinical and scientific information for the benefit of patients, colleagues, fellows and residents.
Find out more here: https://www.americanglaucomasociety.net/ags-events/annual-meeting
